These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38688401)

  • 21. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of tumor stemness and immunity related prognostic factors and sensitive drugs in head and neck squamous cell carcinoma.
    Ye Z; Xiao M; Zhang Y; Zheng A; Zhang D; Chen J; Du F; Zhao Y; Wu X; Li M; Chen Y; Deng S; Shen J; Zhang X; Wen Q; Zhang J; Xiao Z
    Sci Rep; 2024 Jul; 14(1):15962. PubMed ID: 38987626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
    Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
    Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
    Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
    Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated DKK1 expression: a promising prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma.
    Jerjes W
    Expert Rev Anticancer Ther; 2024 Sep; 24(9):917-919. PubMed ID: 38989818
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DYNC1I1 acts as a promising prognostic biomarker and is correlated with immune infiltration in head and neck squamous cell carcinoma.
    Ananya RG; Pandi C; Kannan B; Pandi A; Prasad P; Jayaseelan VP; Arumugam P
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4):101734. PubMed ID: 38072235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
    Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Reid PA; Wilson P; Li Y; Marcu LG; Bezak E
    Head Neck; 2017 Sep; 39(9):1920-1932. PubMed ID: 28644558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C
    Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
    Li Z; Wu X; Li J; Yu S; Ke X; Yan T; Zhu Y; Cheng J; Yang J
    Exp Cell Res; 2022 Sep; 418(1):113271. PubMed ID: 35764101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response.
    Reid P; Marcu LG; Olver I; Moghaddasi L; Staudacher AH; Bezak E
    Radiother Oncol; 2019 Jun; 135():1-12. PubMed ID: 31015153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B
    J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of BMI1 as a biomarker of cancer stem cells in head and neck cancer: a review.
    Allegra E; Trapasso S; Pisani D; Puzzo L
    Oncology; 2014; 86(4):199-205. PubMed ID: 24800958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex interaction and heterogeneity among cancer stem cells in head and neck squamous cell carcinoma revealed by single-cell sequencing.
    Xiao M; Zhang X; Zhang D; Deng S; Zheng A; Du F; Shen J; Yue L; Yi T; Xiao Z; Zhao Y
    Front Immunol; 2022; 13():1050951. PubMed ID: 36451812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole exome sequencing approach to analysis of the origin of cancer stem cells in patients with head and neck squamous cell carcinoma.
    Salazar-García L; Pérez-Sayáns M; García-García A; Carracedo Á; Cruz R; Lozano A; Sobrino B; Barros F
    J Oral Pathol Med; 2018 Nov; 47(10):938-944. PubMed ID: 30067878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
    Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC.
    Jakob M; Sharaf K; Schirmer M; Leu M; Küffer S; Bertlich M; Ihler F; Haubner F; Canis M; Kitz J
    Strahlenther Onkol; 2021 Mar; 197(3):231-245. PubMed ID: 32588101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.